Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Sensei Bio logo — We follow the immune system’s teachings to discover new trea...

Sensei Bio

We follow the immune system’s teachings to discover new treatments that inspire the body to fight cancer.

Founded 1999 United States Rockville, United States 32 employees Series B Total: $58.50M Biotechnology, Health Care +2

General Information

Company Name Sensei Bio
Founded Year 1999
Location United States Rockville, United States
Founders / Decision Makers
Team member Team member Team member
Employees 32
Industries Biotechnology, Health Care, Health and Wellness +1
Funding Stage Series B
Business Model B2B, B2B2C
Revenue Model Licensing, Performance Based
Social

BounceWatch is an independent company data service, not affiliated with Sensei Bio. To contact Sensei Bio, visit senseibio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Sensei Bio compare?

A PDF of Sensei Bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Sensei Bio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Sensei Bio

Sensei Bio, founded in 1999, is a pioneering player in the Biotechnology and Life Sciences sectors, focused on developing cutting-edge immuno-oncology therapies. Their compelling slogan, "We follow the immune system’s teachings to discover new treatments that inspire the body to fight cancer," succinctly captures their mission.

With headquarters in the United States, Sensei Bio has developed the TMAb™ platform, which enhances the body's immune response by targeting the tumor microenvironment. Their strategic focus on leveraging immunology insights to effectively treat cancer as an infection positions them uniquely within the industry.

Their last funding round was a $30.00M Series B, dated January 11, 2021, with participation from prestigious investors like Future Ventures, Pura Vida Investments, Apeiron Investment Group, among others. This investment underscores the strong confidence in Sensei Bio's potential to revolutionize cancer treatment through innovative therapeutic platforms.

Business keywords: Immunotherapy, Cancer treatment, Drug discovery, Clinical-stage biotech, Cancer immunotherapies, Tumor microenvironment, Next-generation therapies, Biologics, ImmunoPhage platform, Biology, Immunology, Oncology, Therapeutics, Clinical research

Services & Products

Research and Development of Cancer Therapeutics
Clinical Trials for Cancer Treatments
Multi-node Inhibition Therapies

Target Customers

Cancer Patients Oncologists Healthcare Providers

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $30.00M 9
Future Ventures Pura Vida Investments Apeiron Investment Group
Future Ventures, Pura Vida Investments +7
11 Jan 2021
Series A $28.50M 1
Future Ventures
Future Ventures
07 Oct 2020

Sensei Bio Alternatives & Competitors

View All Alternatives
Sensei Bio vs
Inceptor Bio
Inceptor Bio United States

Advancing Cell and Gene Therapies to Cure Cancer

Debt Financing
28 employees
Biotechnology, Health Care
Compare Sensei Bio vs Inceptor Bio
Sensei Bio vs
OncoResponse
OncoResponse United States

Interrogating for Cures

10 employees
Biopharma, Biotechnology
Compare Sensei Bio vs OncoResponse
Sensei Bio vs
Mestastop® Solutions
Mestastop® Solutions United States

Stopping Metastasis, giving life a second chance

Seed
18 employees
Biotechnology, Life Sciences
Also compare with: Sensei Bio vs BioAtla, Inc. BioAtla, Inc. View all alternatives

FAQ About Sensei Bio

We follow the immune system’s teachings to discover new treatments that inspire the body to fight cancer.
Sensei Bio was founded in 1999.
Sensei Bio is headquartered in Rockville, United States.
Sensei Bio operates in Biotechnology, Health Care, Health and Wellness and Life Sciences. Its work centres on Immunotherapy, Cancer treatment, Drug discovery and Clinical-stage biotech. Its customers include Cancer Patients, Oncologists and Healthcare Providers.
Sensei Bio has a B2B and B2B2C business model. Its revenue comes from Licensing and Performance Based.
Sensei Bio has approximately 32 employees.
Sensei Bio has completed 2 funding rounds, raising a total of $58.50M. The latest funding stage is Series B.
Sensei Bio offers: Research and Development of Cancer Therapeutics, Clinical Trials for Cancer Treatments, Multi-node Inhibition Therapies.
Top alternatives and competitors to Sensei Bio include Inceptor Bio, OncoResponse, Mestastop® Solutions, Cytimmune Sciences, BioAtla, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sensei Bio and Inceptor Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Sensei Bio, https://bouncewatch.com/company/sensei-bio, updated 18 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes